Chongqing Taiji Industry Group Company Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
10,864
- Stock Symbol
-
600129
- Investments
-
1
- Share Price
-
$1.85
- (As of Friday Closing)
Chongqing Taiji Industry Group Company General Information
Description
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
Contact Information
Website
www.taiji.comCorporate Office
- Huanglong Road No 38, Wong Nai pounds dragon tower street
- Yuzhong District
- Chongqing, 401147
- China
Corporate Office
- Huanglong Road No 38, Wong Nai pounds dragon tower street
- Yuzhong District
- Chongqing, 401147
- China
Chongqing Taiji Industry Group Company Stock Performance
As of 13-Nov-2026, Chongqing Taiji Industry Group Company’s stock price is $1.85. Its current market cap is $1.02B with 551M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.85 | $1.89 | $1.70 - $2.94 | $1.02B | 551M | 12.9M |
Chongqing Taiji Industry Group Company Financials Summary
As of 30-Sep-2026, Chongqing Taiji Industry Group Company has a trailing 12-month revenue of $1.39B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 1,846,918 | 2,102,120 | 2,443,462 | 4,053,369 |
| Revenue | 1,391,105 | 1,460,097 | 1,726,163 | 2,208,186 |
| EBITDA | 26,826 | 114,093 | 122,023 | 223,908 |
| Net Income | (2,847) | 16,766 | 3,714 | 116,203 |
| Total Assets | 2,099,558 | 2,059,741 | 1,925,694 | 2,033,092 |
| Total Debt | 810,476 | 776,300 | 698,372 | 596,014 |
Chongqing Taiji Industry Group Company Patents
Chongqing Taiji Industry Group Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022047729-A1 | Anti-diarrheal suppository traditional chinese medicine composition, and preparation method therefor and use thereof | Inactive | 04-Sep-2020 | ||
| WO-2022047726-A1 | Traditional chinese medicine composition for treating dermatosis, preparation method therefor and use thereof | Inactive | 04-Sep-2020 | ||
| WO-2021195904-A1 | Use of composition containing astragali radix, puerariae lobatae radix and erigerontis herba | Inactive | 31-Mar-2020 | ||
| WO-2019228210-A1 | Pharmaceutical use of composition comprising radix astragali, radix puerariae, and herba erigerontis | Inactive | 28-May-2018 |
Chongqing Taiji Industry Group Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Chongqing Taiji Industry Group Company Acquisitions (1)
Chongqing Taiji Industry Group Company’s most recent deal was a Merger/Acquisition with Southwest Pharmaceutical Company. The deal was made on 17-May-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Southwest Pharmaceutical Company | 17-May-2013 | Merger/Acquisition | Pharmaceuticals |
Chongqing Taiji Industry Group Company ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
40.02 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Chongqing Taiji Industry Group Company Exits (1)
Chongqing Taiji Industry Group Company’s most recent exit was on 17-May-2013 from Southwest Pharmaceutical Company. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Southwest Pharmaceutical Company | 17-May-2013 | Completed |
|
Chongqing Taiji Industry Group Company FAQs
-
When was Chongqing Taiji Industry Group Company founded?
Chongqing Taiji Industry Group Company was founded in 1993.
-
Where is Chongqing Taiji Industry Group Company headquartered?
Chongqing Taiji Industry Group Company is headquartered in Chongqing, China.
-
What is the size of Chongqing Taiji Industry Group Company?
Chongqing Taiji Industry Group Company has 10,864 total employees.
-
What industry is Chongqing Taiji Industry Group Company in?
Chongqing Taiji Industry Group Company’s primary industry is Pharmaceuticals.
-
Is Chongqing Taiji Industry Group Company a private or public company?
Chongqing Taiji Industry Group Company is a Public company.
-
What is Chongqing Taiji Industry Group Company’s stock symbol?
The ticker symbol for Chongqing Taiji Industry Group Company is 600129.
-
What is the current stock price of Chongqing Taiji Industry Group Company?
As of 13-Nov-2026 the stock price of Chongqing Taiji Industry Group Company is $1.85.
-
What is the current market cap of Chongqing Taiji Industry Group Company?
The current market capitalization of Chongqing Taiji Industry Group Company is $1.02B.
-
What is Chongqing Taiji Industry Group Company’s current revenue?
The trailing twelve month revenue for Chongqing Taiji Industry Group Company is $1.39B.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
